TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress

Jay R Anand1, Gaith N Droby2, Sayali Joseph1

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.

NAR Cancer
|March 21, 2025
PubMed

Insights

Oncogene activation causes DNA replication stress, requiring DNA damage response (DDR) for survival. We found TRIP13 is essential for KRAS-mutant pancreatic cancer cells, offering a new therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Oncogene activation in normal cells triggers DNA replication stress, creating a dependency on DNA damage response (DDR) pathways for survival.
  • The DDR is pathologically altered in various cancers, with distinct oncogenic stimuli employing unique signaling mechanisms.
  • Mutant KRAS drives 90% of pancreatic ductal adenocarcinomas (PDACs), highlighting the need to understand KRAS-induced DDR in this cancer.

Purpose of the Study:

  • To investigate the DDR mechanisms that enable tolerance of KRAS-induced DNA replication stress in normal human pancreatic epithelial cells (HPNE cells).
  • To identify novel DDR players involved in KRAS-driven pancreatic cancer.
  • To explore TRIP13 as a potential therapeutic vulnerability in KRAS-mutant PDAC.

Main Methods:

  • Candidate screening approach to identify KRAS-induced genes.
  • Genetic and pharmacological tools to assess TRIP13 function in KRASG12V-expressing HPNE cells.
  • Evaluation of homologous recombination (HR) dependency and sensitivity to genotoxic agents and inhibitors in TRIP13-depleted cells and PDAC cell lines.

Main Results:

  • TRIP13 mRNA is upregulated by KRASG12V and highly expressed in PDAC compared to normal tissues.
  • TRIP13 is essential for DNA synthesis and viability in KRASG12V-expressing cells.
  • TRIP13 depletion in KRASG12V-expressing cells leads to HR deficiency phenotypes and sensitivity to translesion synthesis and PARP inhibitors.
  • TRIP13 depletion sensitizes established PDAC cell lines to DNA damage and genotoxic therapies.

Conclusions:

  • TRIP13 is a KRASG12V-induced gene crucial for maintaining DNA synthesis and survival in KRAS-mutant pancreatic cells.
  • TRIP13 functions in a homologous recombination-dependent manner, and its depletion confers sensitivity to HR deficiency-associated liabilities.
  • TRIP13 represents a novel and therapeutically actionable vulnerability in KRAS-mutant pancreatic ductal adenocarcinoma.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K
The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
35.3K